FARLEY CAPITAL L.P. - Q2 2023 holdings

$92.1 Million is the total value of FARLEY CAPITAL L.P.'s 11 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 8.3% .

 Value Shares↓ Weighting
MA SellMASTERCARD INCcl a$28,297,935
+4.6%
71,950
-3.3%
30.74%
-1.4%
MSFT SellMICROSOFT CORP$17,826,928
+17.4%
52,349
-0.6%
19.37%
+10.7%
GOOG BuyALPHABET INCcap stk cl c$17,795,534
+16.5%
147,107
+0.1%
19.33%
+9.8%
FB  META PLATFORMS INCcl a$9,666,634
+35.4%
33,6840.0%10.50%
+27.6%
ATGE BuyADTALEM GLOBAL ED INC$9,167,990
-8.4%
266,977
+3.0%
9.96%
-13.7%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$5,160,699
-18.4%
61,9160.0%5.61%
-23.1%
MCHI  MSCI CHINA ETF$1,303,053
-10.3%
29,1250.0%1.42%
-15.5%
GOOGL  ALPHABET INCcap stk cl a$1,189,818
+16.0%
9,9400.0%1.29%
+9.3%
BRKB  BERKSHIRE HATHAWAY INC DELcl b$1,011,406
+10.4%
2,9660.0%1.10%
+4.1%
BRKA  BERKSHIRE HATHAWAY INC DELcl a$517,810
+11.2%
10.0%0.56%
+4.8%
 BLUE FOUNDRY BANCORP$113,869
+6.2%
11,2630.0%0.12%0.0%
ExitMETA PLATFORMS INC$0-8,500
-100.0%
-2.08%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MASTERCARD INC35Q3 202343.3%
BERKSHIRE HATHAWAY INC DEL35Q3 20232.6%
BERKSHIRE HATHAWAY INC DEL28Q3 20230.6%
ALPHABET INC25Q3 202320.9%
ALPHABET INC25Q3 20231.4%
ADTALEM GLOBAL ED INC19Q3 202356.8%
VALEANT PHARMACEUTICALS INTL19Q4 201730.1%
DEVRY INC DEL16Q1 201758.4%
META PLATFORMS INC16Q3 202311.7%
PRAXAIR INC13Q4 20173.6%

View FARLEY CAPITAL L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)

View FARLEY CAPITAL L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-08
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-11
13F-HR2022-02-14
13F-HR2021-11-15

View FARLEY CAPITAL L.P.'s complete filings history.

Compare quarters

Export FARLEY CAPITAL L.P.'s holdings